價格 | 詢價 | ||
包裝 | 50μg | 100μg | 1mg |
最小起訂量 | 50μg |
發(fā)貨地 | 上海 |
更新日期 | 2023-10-16 |
中文名稱:2019-nCoV S蛋白 | 英文名稱:Recombinant 2019-nCoV S protein RBD Protein (C-mFc) |
產(chǎn)品類別: 重組蛋白 |
描述:
Recombinant 2019-nCoV S Protein RBD is produced by our Mammalian expression system and the target gene encoding Asn331-Val524 is expressed with a mFc tag at the C-terminus.
Accession: QHD43416.1
別名:S protein RBD; 2019-nCoV S protein RBD
來源:Human Cells
分子量:Mol Mass: 47.9kDa AP Mol Mass: 50-60kDa, reducing conditions
形態(tài):Supplied as a 0.2 μM filtered solution of PBS, pH 7.4
純化方法:Affinity purification chromatography.
純度:Greater than 95% as determined by reducing SDS-PAGE.
活性:The ED50 of 2019-nCoV S Protein RBD-mFc is 62 ng/ml.
儲存/保存方法:Reconstituted protein solution should be stored at ≤ -20°C.
背景說明:
Protein S (PROS1) is glycoprotein and expressed in many cell types supporting its reported involvement in multiple biological processes that include coagulation, apoptosis, cancer development and progression, and the innate immune response. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2, DPP4, CEACAM etc.. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.
愛必信可提供蛋白定*務(wù):
愛必信擁有經(jīng)驗豐富的專業(yè)技術(shù)人員,服務(wù)內(nèi)容包括基因合成,密碼子優(yōu)化,表達(dá)載體設(shè)計,大規(guī)模細(xì)胞培養(yǎng)和發(fā)酵,蛋白質(zhì)純化和質(zhì)量控制測試。定制的重組蛋白產(chǎn)品100%穩(wěn)定可溶、上清液純化蛋白更接近天然結(jié)構(gòu)、低內(nèi)毒素控制、純度可按需定制,提供檢測報告。
愛必信重組蛋白
愛必信新冠狀病毒(n-Cov)相關(guān)蛋白,歡迎咨詢選購!
成立日期 | 2010-12-13 (15年) | 注冊資本 | 2500萬 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1000萬-5000萬 |
主營行業(yè) | 生化試劑,抗體,分子生物學(xué),生物活性小分子 | 經(jīng)營模式 | 工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
¥4800 |
VIP6年
|
上??道噬锟萍加邢薰?/div>
|
2025-04-14 | |
¥65 |
VIP7年
|
湖北鴻鑫瑞宇精細(xì)化工有限公司
|
2025-04-14 | |
詢價 |
VIP6年
|
上?;菡\生物科技有限公司
|
2025-04-14 |